10x Genomics company profile
Company profile
10x Genomics has 1,178 employees and is headquartered in Pleasanton, United States.
Based in Pleasanton, California, and in existence since 2012, 10x Genomics supplies researchers with tools for studying biological samples at the level of individual cells and tissue locations. Its Chromium system covers single-cell analysis through microfluidic chips, reagents and kits, while the Visium platform maps gene expression across tissue slides and the Xenium Analyzer detects RNA targets in situ. Customers include academic and government institutions, biopharmaceutical companies and biotechnology firms, served across the United States, Europe, the Middle East, Africa, China and the rest of Asia Pacific. Software such as Cell Ranger, Loupe Browser and Xenium Explorer completes the offering.
In the fiscal year ended December 2025, the company reported revenue of 642.8 million US dollars, up 5.2% from the previous year, and a net loss of 43.5 million US dollars. It employed 1,178 people. By region, the United States accounted for 53.9% of revenue, EMEA for 25.2% and China for 10.9%, with Asia Pacific excluding China at 8.1% and the Americas excluding the United States at 1.9%.
Company facts
- Sector
- Healthcare
- Industry
- Medical Devices
- Country
- United States
- Headquarters
- 6230 Stoneridge Mall Road, 94588-3260, Pleasanton
- Employees
- 1,178
- Chief executive
- Serge Saxonov
- Founded
- 2012
- Fiscal year
- January - December
- Listing
- TXG · NASDAQ
- Currency
- USD
- ISIN
- US88025U1097
- Website
- 10xgenomics.com
10x Genomics and its competitors
The most similar companies by business and size
| Company | Country | Market cap | Employees | Operating margin | P/E (trailing 12 months) |
|---|---|---|---|---|---|
| 10x GenomicsTXG | United States | $7.65B | 1,178 | -10.6% | — |
| InsuletPODD | United States | $10.08B | 5,400 | 18.4% | 23.7 |
| PenumbraPEN | United States | $12.64B | 4,700 | 12.1% | 80.8 |
| Zimmer Biomet HoldingsZBH | United States | $19.19B | 17,000 | 16.7% | 25.6 |
| SterisSTE | United States | $25B | 17,937 | 19.2% | 30.5 |
| DexComDXCM | United States | $30.44B | 11,000 | 24.0% | 32.1 |
Competitors: same or related industry, same region first, then the closest market capitalization. Market cap converted into US dollars at the latest exchange rates; P/E over the last 12 months, not shown when negative.
